A Fresh Approach to Targeting Aging Cells: CAR-T Cells Enhance Senolytic Specificity
- PMID: 32763179
- PMCID: PMC7717659
- DOI: 10.1016/j.stem.2020.07.010
A Fresh Approach to Targeting Aging Cells: CAR-T Cells Enhance Senolytic Specificity
Abstract
Senescence is a critical factor in several diseases, yet senolytic therapies targeting senescent cells remain hindered by lack of specificity. In the June issue of Nature, Amor et al. (2020) develop chimeric antigen receptor (CAR)-T cells targeting uPAR, a novel senescent-cell marker, to treat liver adenocarcinoma and liver fibrosis.
Copyright © 2020 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of Interests Y.Y.C. is the inventor of the following patents on technologies mentioned in this Preview: US15/772403, on TGF-b CARUS15/535972, on CD19/CD20 bispecific CAR for B-cell lymphoma. The patents are all assigned to the Regents of the University of California.
Figures
Comment on
-
Senolytic CAR T cells reverse senescence-associated pathologies.Nature. 2020 Jul;583(7814):127-132. doi: 10.1038/s41586-020-2403-9. Epub 2020 Jun 17. Nature. 2020. PMID: 32555459 Free PMC article.
References
-
- Deeks SG, Wagner B, Anton PA, Mitsuyasu RT, Scadden DT, Huang C, Macken C, Richman DD, Christopherson C, June CH, et al. (2002). A phase II randomized study of HIV-specific T-cell gene therapy in subjects with undetectable plasma viremia on combination antiretroviral therapy. Mol. Ther 5, 788–797. - PubMed
